Polymorphisms of Insulin-Like Growth Factor Binding Protein-3 As a Predictor for Risk and Patient Survival in Esophageal Squamous Cell Carcinoma

Lei Zhao,Feng Chi,Mian Xi,Jing-Xian Shen,Qiao-Qiao Li,Li-Ru He,Shi-Liang Liu,Meng-Zhong Liu
DOI: https://doi.org/10.1016/j.biopha.2015.08.021
IF: 7.419
2015-01-01
Biomedicine & Pharmacotherapy
Abstract:Background and purpose: Genetic single nucleotide polymorphisms (SNP) play a critical role in the development of esophageal squamous cell carcinoma (ESCC). The aim of this study is to investigate the associations between insulin-like growth factor binding protein-3 (IGFBP-3) gene polymorphisms and ESCC patients risk and survival after definitive chemoradiotherapy (CRT).Materials and methods: We undertook a case-control study to analyze two IGFBP-3 polymorphisms (rs2854744 A > C and rs2854746 G > C) in an Han Chinese population, by extraction of genomic DNA from the peripheral blood of 110 ESCC patients treated with CRT and 128 control participants, and performed IGFBP-3 genotyping using DNA sequencing.Results: The obtained results indicated that overall, no statistically significant association was observed in rs2854746 G > C. However, rs2854744 A > C genotype was at increased risk of ESCCs (P = 0.032; odds ratio (OR) = 1.201, CI 95%: 1.014-1.423). Moreover, rs2854744 A > C genotype ESCCs were more significantly common in patients with tumor size of >6 cm than A allele ESCC and in cases of lower T stage. Furthermore, ESCC patients with rs2854744CC genotype have the poorer CRT response and shorter survival time than GG + GC genotype ESCC.Conclusions: In conclusion, polymorphism in IGFBP-3 rs2854744 A > C might be a potential predictor of ESCC risk and patient survival. Nevertheless, further investigation with a larger sample size is needed to support our results. (C) 2015 Elsevier Masson SAS. All rights reserved.
What problem does this paper attempt to address?